Key terms

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MRNA news

Apr 11 11:59am ET Moderna (NASDAQ:MRNA) Postpones Plans of Vaccine Plant in Kenya Apr 11 6:34am ET Moderna pauses efforts to build vaccine plant in Kenya, FT says Apr 09 1:32pm ET Moderna’s (NASDAQ:MRNA) Latest Treatment Line Gives Shares New Life Apr 09 8:10am ET Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Ocugen (OCGN) and Moderna (MRNA) Apr 09 7:13am ET Analysts Are Bullish on These Healthcare Stocks: Inozyme Pharma (INZY), Moderna (MRNA) Apr 08 11:00pm ET Wall Street Analysts Are Bullish on Top Healthcare Picks Apr 08 2:43pm ET Moderna Stock (NASDAQ:MRNA): This mRNA Tech Pioneer Has Rebound Potential Apr 04 8:38am ET Arbutus ‘pleased’ with claim construction ruling in patent infringement suit Apr 03 3:05pm ET Moderna could owe $1B-$3B in royalties, says Jefferies Apr 03 2:02pm ET Roivant, Arbutus higher after ruling on COVID patent order Apr 03 1:56pm ET Jefferies sees Roivant rallying 5%-10% on today’s COVID patent order Apr 03 11:07am ET Moderna announces publication of Phase 1/2 interim data on mRNA-3927 Apr 02 8:10am ET Analysts Are Bullish on Top Healthcare Stocks: Veeva Systems (VEEV), Moderna (MRNA) Mar 29 3:07am ET Maintaining Sell Rating on Moderna Amid Financial Strains and Competitive Pressures Mar 28 8:00am ET Analysts Are Bullish on Top Healthcare Stocks: Moderna (MRNA), Altimmune (ALT) Mar 28 7:55am ET Buy Rating Affirmed for Moderna Amid Strategic Partnerships and Promising Vaccine Pipeline Mar 28 7:05am ET Balancing Scientific Progress with Market Realities: Moderna’s Hold Rating Explained Mar 28 7:00am ET Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Akebia Therapeutics (AKBA) and Moderna (MRNA) Mar 28 6:35am ET RBC Capital Sticks to Its Buy Rating for Moderna (MRNA) Mar 28 5:55am ET Moderna’s Promising Vaccine Pipeline Balanced with Near-Term Caution: Hold Rating Maintained Mar 28 5:01am ET Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Argenx Se (ARGX) and NovoCure (NVCR) Mar 27 8:45am ET Moderna to host investor event Mar 27 6:39am ET Moderna advances multiple vaccine programs to clinical trials Mar 27 6:37am ET Blackstone to provide up to $750M to fund Moderna’s influenza program Mar 27 5:55am ET Moderna to host investor event Mar 26 5:19pm ET Moderna to host investor event Mar 26 10:41am ET Moderna’s Next-Gen COVID Vaccine Triumphs in Trial Mar 25 9:56am ET Early notable gainers among liquid option names on March 25th Mar 19 8:11am ET Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), Moderna (MRNA) and Monte Rosa Therapeutics (GLUE) Mar 19 12:19am ET Novavax (NASDAQ:NVAX): A Highly Speculative Value Trade in the Post-Pandemic Era Mar 18 8:16pm ET Cathie Wood’s ARK Investment bought 151K shares of Moderna today

MRNA Financials

1-year income & revenue

Key terms

MRNA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MRNA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms